Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine

Clinical Toxicology

Volumn 53, Issue 5, 2015, Pages 446-453

  Helander, Anders ^a   Beck, Olof ^a   Bäckberg, Matilda ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Swedish Poisons Information Centre   (Sweden)

Author keywords

Diphenidine; Dissociative drugs; LC MS; Legal highs; Methoxphenidine; New psychoactive substance; NMDA receptor antagonist; Research chemicals; Severe adverse events; STRIDA project

Indexed keywords

2 4 BROMOMETHCATHINONE; 3 METHOXYPHENCYCLIDINE; 3,4 DICHLOROMETHYLPHENIDATE; 4 METHOXYPHENCYCLIDINE; 5 (2 AMINOPROPYL)BENZOFURAN; 5 METHOXY N ISOPROPYLTRYPTAMINE; 6 (2 AMINOPROPYL)BENZOFURAN; ALCOHOL; ALPHA PYRROLIDINOPENTIOTHIOPHENONE; ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; BUTYLONE; CANNABIS; DEXMEDETOMIDINE; DIAZEPAM; DIPHENIDINE; FLUMAZENIL; HALOPERIDOL; KETAMINE; METHIOPROPAMINE; METHOXETAMINE; METHOXPHENIDINE; MIDAZOLAM; NALOXONE; PROPOFOL; PSYCHOTROPIC AGENT; REMIFENTANIL; UNCLASSIFIED DRUG; 1-(1-(2-METHOXYPHENYL)-2-PHENYLETHYL)PIPERIDINE; PIPERIDINE DERIVATIVE; STREET DRUG;

ADOLESCENT; ADULT; ALCOHOL ABUSE; ANXIETY; ARTICLE; BLOOD SAMPLING; CANNABIS ADDICTION; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; DIPHENIDINE INTOXICATION; DISORIENTATION; DRUG ABUSE; EMERGENCY WARD; FEMALE; HALLUCINATION; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INTENSIVE CARE; INTOXICATION; LENGTH OF STAY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEDICAL RECORD REVIEW; MENTAL DISEASE; MENTAL DISSOCIATION; METHOXPHENIDINE INTOXICATION; NYSTAGMUS; OBSERVATIONAL STUDY; OXYGEN THERAPY; PATIENT CARE; POISONING SEVERITY SCORE 3; SCORING SYSTEM; SWEDEN; TACHYCARDIA; TELECONSULTATION; URINALYSIS; BLOOD; DRUG OVERDOSE; ECONOMICS; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; HOSPITAL COST; MIDDLE AGED; POISON CENTER; PREDICTIVE VALUE; PROCEDURES; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE; TIME; TREATMENT OUTCOME; URINE; YOUNG ADULT;

CANNABIS;

ADULT; CHROMATOGRAPHY, LIQUID; DRUG OVERDOSE; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PIPERIDINES; POISON CONTROL CENTERS; POISONING; PREDICTIVE VALUE OF TESTS; PSYCHOTROPIC DRUGS; SEVERITY OF ILLNESS INDEX; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84929086796     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2015.1033630     Document Type: Article

References (38)

1. Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011; 49:705-719.
2. Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int 2014; 243:23-29.
3. EMCDDA. Risk assessments of various psychoactive substances 1999-2014. 2014. http://www.emcdda.europa.eu/publications/searchr esults?action ? list&type ? PUBLICATIONS&SERIES-PUB ? w12 (Accessed on March 2015).
4. Helander A, Bäckberg M, Beck O. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 2014; 52:901-904.
5. Kronstrand R, Thelander G, Lindstedt D, Roman M, Kugelberg FC. Fatal intoxications associated with the designer opioid AH-7921. J Anal Toxicol 2014; 38:599-604.
6. Vorce SP, Knittel JL, Holler JM, Magluilo J Jr., Levine B, Berran P, Bosy TZ. A fatality involving AH-7921. J Anal Toxicol 2014; 38:226-230.
7. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983; 79:565-575.
8. Berger ML, Schweifer A, Rebernik P, Hammerschmidt F. NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl) piperidine enantiomers and of related compounds. Bioorg Med Chem 2009; 17:3456-3462.
9. Morris H, Wallach J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 2014; 6:614-632.
10. Wallach J, De Paoli G, Adejare A, Brandt SD. Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues. Drug Test Anal 2014; 6:633-650.
11. Dargan PI, Wood DM. Recreational drug use in the Asia Pacific region: Improvement in our understanding of the problem through the UNODC programmes. J Med Toxicol 2012; 8:295-299.
12. Zhao Q, Brady JE, Lang BH, Rebok GW, DiMaggio C. Drug violations and aviation accidents: findings from the US mandatory drug testing programs. Addiction 2011; 106:1287-1292.
13. Platteborze PL, Kippenberger DJ, Martin TM. Drug positive rates for the Army, Army Reserve, and Army National Guard from fiscal year 2001 through 2011. Mil Med 2013; 178:1078-1084.
14. Bokor G, Anderson PD. Ketamine: an update on its abuse. J Pharm Pract 2014; 27:582-586.
15. deRoux SJ, Sgarlato A, Marker E. Phencyclidine: a 5-year retrospective review from the New York City Medical Examiner's Office. J Forensic Sci 2011; 56:656-659.
16. Xu J, Lei H. Ketamine-an update on its clinical uses and abuses. CNS Neurosci Ther 2014; 20:1015-1020.
17. Misselbrook GP, Hamilton EJ. Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs. Acute Med 2012; 11:157-160.
18. Hofer KE, Degrandi C, Muller DM, Zurrer-Hardi U, Wahl S, Rauber-Luthy C, Ceschi A. Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine. Clin Toxicol (Phila) 2014; 52:1288-1291.
19. Wallach J, Kavanagh PV, McLaughlin G, Morris N, Power JD, Elliott SP, et al. Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Drug Test Anal 2014. doi: 10.1002/dta.1689.
20. Helander A, Beck O, Hägerkvist R, Hultén P. Identification of novel psychoactive drug use in Sweden based on laboratory analysis-initial experiences from the STRIDA project. Scand J Clin Lab Invest 2013; 73:400-406.
21. Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 36:205-213.
22. Starmark JE, Stålhammar D, Holmgren E, Rosander B. A comparison of the Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg 1988; 69:699-706.
23. Bäckberg M, Beck O, Hultén P, Rosengren-Holmberg J, Helander A. Intoxications of the new psychoactive substance 5-(2-aminopropyl) indole (5-IT): a case series from the Swedish STRIDA project. Clin Toxicol (Phila) 2014; 52:618-624.
24. Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 930:112-120.
25. Mannelli P, Janiri L, De Marinis M, Tempesta E. Lefetamine: new abuse of an old drug-clinical evaluation of opioid activity. Drug Alcohol Depend 1989; 24:95-101.
26. Bäckberg M, Lindeman E, Beck O, Helander A. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila) 2015; 53:46-53.
27. Bluelight.org. The Big & Dandy Diphenidine Thread. http://www. bluelight.org/vb/threads/668291-The-Big-amp-Dandy-Diphenidine-Thread. (Accessed on December 2014).
28. Drugs-Forum.com. Diphenidine (1,2-diphenylethylpiperidine) drug info. https://www.drugs-forum.com/forum/showthread.php?t?210615. (Accessed on December 2014).
29. Bluelight.org. The Big & Dandy Methoxphenidine/MXP/2-MeO-Diphenidine Thread. http://www.bluelight.org/vb/threads/700834-The-Big-amp-Dandy-Methoxphenidine-(MXP-2-MeO-Diphenidine)-Thread. (Accessed on December 2014).
30. Drugs-Forum.com. Methoxphenidine (2-MeO-diphenidine) Drug Info. https://www.drugs-forum.com/forum/showthread.php?t?231278. (Accessed on December 2014).
31. Flashback.org. Diphenidine. https://www.flashback.org/t2254547. (Accessed on December 2014).
32. Flashback.org. Methoxphenidine/MXP/2-MeO-Diphenidine. https:// www.flashback.org/t2266154. (Accessed on December 2014).
33. Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 2012; 68:853-856.
34. Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, et al. Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol 2014. doi: 10.1007/ s11419-014-0245-6.
35. Elliott S, Brandt SD, Wallach J, Morris H, Kavanagh PV. First reported fatalities associated with the 'research chemical' 2-methoxydiphenidine. J Anal Toxicol 2015. doi: 10.1093/jat/bkv006.
36. Uchiyama N, Shimokawa Y, Kawamura M, Kikura-Hanajiri R, Hakamatsuka T. Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol 2014; 32:266-281.
37. Wurita A, Hasegawa K, Minakata K, Watanabe K, Suzuki O. A large amount of new designer drug diphenidine coexisting with a synthetic cannabinoid 5-fluoro-AB-PINACA found in a dubious herbal product. Forensic Toxicol 2014; 32:331-337.
38. Strano Rossi S, Odoardi S, Gregori A, Peluso G, Ripani L, Ortar G, et al. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials. Rapid Commun Mass Spectrom 2014; 28:1904-1916.